Literature DB >> 31021331

Heterogeneity of the action potential duration is required for sustained atrial fibrillation.

Uma Mahesh R Avula1, Jeffrey Abrams1, Alexander Katchman1, Sergey Zakharov1, Sergey Mironov2, Joseph Bayne1, Daniel Roybal1, Anirudh Gorti1, Lin Yang1, Vivek Iyer3, Marc Waase1, Deepak Saluja1, Edward J Ciaccio1, Hasan Garan1, Andrew R Marks4,5, Steven O Marx1, Elaine Y Wan1.   

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia and accounts for substantial morbidity and mortality. Recently, we created a mouse model with spontaneous and sustained AF caused by a mutation in the NaV1.5 channel (F1759A) that enhances persistent Na+ current, thereby enabling the investigation of molecular mechanisms that cause AF and the identification of novel treatment strategies. The mice have regional heterogeneity of action potential duration of the atria similar to observations in patients with AF. In these mice, we found that the initiation and persistence of the rotational reentrant AF arrhythmias, known as spiral waves or rotors, were dependent upon action potential duration heterogeneity. The centers of the rotors were localized to regions of greatest heterogeneity of the action potential duration. Pharmacologically attenuating the action potential duration heterogeneity reduced both spontaneous and pacing-induced AF. Computer-based simulations also demonstrated that the action potential duration heterogeneity is sufficient to generate rotors that manifest as AF. Taken together, these findings suggest that action potential duration heterogeneity in mice and humans is one mechanism by which AF is initiated and that reducing action potential duration heterogeneity can lessen the burden of AF.

Entities:  

Keywords:  Arrhythmias; Cardiology; Cell Biology; Ion channels; Mouse models

Mesh:

Substances:

Year:  2019        PMID: 31021331      PMCID: PMC6629142          DOI: 10.1172/jci.insight.128765

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  30 in total

1.  Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart.

Authors:  M L Valencik; J A McDonald
Journal:  Transgenic Res       Date:  2001-06       Impact factor: 2.788

2.  Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue.

Authors:  Z Qu; A Garfinkel; P S Chen; J N Weiss
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

Review 3.  Current status of monophasic action potential recording: theories, measurements and interpretations.

Authors:  M R Franz
Journal:  Cardiovasc Res       Date:  1999-01       Impact factor: 10.787

4.  Cellular basis for the monophasic action potential. Which electrode is the recording electrode?

Authors:  Masahiko Kondo; Vladislav Nesterenko; Charles Antzelevitch
Journal:  Cardiovasc Res       Date:  2004-09-01       Impact factor: 10.787

Review 5.  Voltage-gated ion channels and gating modifier toxins.

Authors:  William A Catterall; Sandrine Cestèle; Vladimir Yarov-Yarovoy; Frank H Yu; Keiichi Konoki; Todd Scheuer
Journal:  Toxicon       Date:  2006-09-28       Impact factor: 3.033

6.  Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.

Authors:  Megan M McNulty; Gabrielle B Edgerton; Ravi D Shah; Dorothy A Hanck; Harry A Fozzard; Gregory M Lipkind
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

7.  Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter.

Authors:  Atsushi Sanbe; James Gulick; Mark C Hanks; Qiangrong Liang; Hanna Osinska; Jeffrey Robbins
Journal:  Circ Res       Date:  2003-03-06       Impact factor: 17.367

8.  Long QT syndrome: from channels to cardiac arrhythmias.

Authors:  Arthur J Moss; Robert S Kass
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

9.  Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.

Authors:  Benjamin M Scirica; David A Morrow; Hanoch Hod; Sabina A Murphy; Luiz Belardinelli; Chester M Hedgepeth; Peter Molhoek; Freek W A Verheugt; Bernard J Gersh; Carolyn H McCabe; Eugene Braunwald
Journal:  Circulation       Date:  2007-09-05       Impact factor: 29.690

10.  A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation.

Authors:  Begoña Benito; Ramon Brugada; Rosa Maria Perich; Eric Lizotte; Juan Cinca; Lluis Mont; Antonio Berruezo; José María Tolosana; Xavier Freixa; Pedro Brugada; Josep Brugada
Journal:  Heart Rhythm       Date:  2008-07-19       Impact factor: 6.343

View more
  11 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Addressing challenges of quantitative methodologies and event interpretation in the study of atrial fibrillation.

Authors:  Edward J Ciaccio; Elaine Y Wan; Deepak S Saluja; U Rajendra Acharya; Nicholas S Peters; Hasan Garan
Journal:  Comput Methods Programs Biomed       Date:  2019-06-15       Impact factor: 5.428

Review 3.  PI3K(p110α) as a determinant and gene therapy for atrial enlargement in atrial fibrillation.

Authors:  Martin Ezeani; Sandeep Prabhu
Journal:  Mol Cell Biochem       Date:  2022-07-28       Impact factor: 3.842

Review 4.  Adrenergic Regulation of Calcium Channels in the Heart.

Authors:  Arianne Papa; Jared Kushner; Steven O Marx
Journal:  Annu Rev Physiol       Date:  2021-11-09       Impact factor: 22.163

Review 5.  Mechanisms of Chronic Metabolic Stress in Arrhythmias.

Authors:  Blake H Gowen; Michael V Reyes; Leroy C Joseph; John P Morrow
Journal:  Antioxidants (Basel)       Date:  2020-10-19

Review 6.  Challenges Associated with Interpreting Mechanisms of AF.

Authors:  Caroline H Roney; Andrew L Wit; Nicholas S Peters
Journal:  Arrhythm Electrophysiol Rev       Date:  2020-02-12

7.  Theoretical Models and Computational Analysis of Action Potential Dispersion for Cardiac Arrhythmia Risk Stratification.

Authors:  Uma Mahesh R Avula; Lea Melki; Jared S Kushner; Stephanie Liang; Elaine Y Wan
Journal:  Front Cardiovasc Med       Date:  2021-03-05

8.  Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress.

Authors:  Uma Mahesh R Avula; Haikel Dridi; Bi-Xing Chen; Qi Yuan; Alexander N Katchman; Steven R Reiken; Amar D Desai; Samantha Parsons; Haajra Baksh; Elaine Ma; Parmanand Dasrat; Ruiping Ji; Yejun Lin; Christine Sison; W Jonathan Lederer; Humberto C Joca; Christopher W Ward; Maura Greiser; Andrew R Marks; Steven O Marx; Elaine Y Wan
Journal:  JCI Insight       Date:  2021-10-28

9.  Involvement of plasminogen activator inhibitor-1 and its related molecules in atrial fibrosis in patients with atrial fibrillation.

Authors:  Qiaoqiao Li; Yingyu Lai; Xiaoyan Gao; Xin Li; Chun-Yu Deng; Huiming Guo; Junfei Zhao; Hui Yang; Yuwen Xu; Shulin Wu; Yumei Xue; Fang Rao
Journal:  PeerJ       Date:  2021-06-02       Impact factor: 2.984

10.  Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding-deficient channels.

Authors:  Jeffrey Abrams; Daniel Roybal; Nourdine Chakouri; Alexander N Katchman; Richard Weinberg; Lin Yang; Bi-Xing Chen; Sergey I Zakharov; Jessica A Hennessey; Uma Mahesh R Avula; Johanna Diaz; Chaojian Wang; Elaine Y Wan; Geoffrey S Pitt; Manu Ben-Johny; Steven O Marx
Journal:  JCI Insight       Date:  2020-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.